Rubicon Research gets SEBI's nod for Rs 1,085 crore IPO

06 Nov 2024 Evaluate

Rubicon Research has received the Securities and Exchange Board of India’s (SEBI's) approval to raise Rs 1,085 crore through an initial public offering (IPO). The company's IPO is a combination of a fresh issue of equity shares worth Rs 500 crore and an Offer For Sale (OFS) of shares valued at Rs 585 crore by promoter, General Atlantic Singapore RR.

The company proposes to utilise proceeds from the fresh issue to the tune of Rs 310 crore for payment of debt. Also, funds will be used for supporting inorganic growth through unidentified acquisitions as well as other strategic initiatives and general corporate purposes. Axis Capital, IIFL Securities, and SBI Capital Markets are the Book Running Lead Managers to the issue.

Rubicon Research is a pharmaceutical formulations company, driven by innovation through focused research and development, with an increasing portfolio of speciality products and drug-device combination products targeting regulated markets and in particular the United States. 


Rubicon Research Share Price

678.80 -3.75 (-0.55%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Wework India Managem 609.40
Rubicon Research 678.80
Aegis Vopak Terminal 216.90
Mallcom 1058.10
Inducto Steel 50.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×